These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26271599)

  • 1. Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review.
    Carlier M; Stove V; Wallis SC; De Waele JJ; Verstraete AG; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Oct; 46(4):367-75. PubMed ID: 26271599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of nine β-lactam antibiotics in human plasma by an ultrafast hydrophilic-interaction chromatography-tandem mass spectrometry.
    Abdulla A; Bahmany S; Wijma RA; van der Nagel BCH; Koch BCP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():138-143. PubMed ID: 28618388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
    Dhaese S; Van Vooren S; Boelens J; De Waele J
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
    Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA
    Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients.
    Wolff F; Deprez G; Seyler L; Taccone F; Hites M; Gulbis B; Vincent JL; Jacobs F; Cotton F
    Talanta; 2013 Jan; 103():153-60. PubMed ID: 23200371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies.
    Sime FB; Roberts MS; Roberts JA; Robertson TA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():134-44. PubMed ID: 24814000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
    Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
    Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?
    Huttner A; Harbarth S; Hope WW; Lipman J; Roberts JA
    J Antimicrob Chemother; 2015 Dec; 70(12):3178-83. PubMed ID: 26188037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
    Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
    Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can changes in renal function predict variations in β-lactam concentrations in septic patients?
    Casu GS; Hites M; Jacobs F; Cotton F; Wolff F; Beumier M; De Backer D; Vincent JL; Taccone FS
    Int J Antimicrob Agents; 2013 Nov; 42(5):422-8. PubMed ID: 23993066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of beta-lactam antibiotics in burns patients--a one-year prospective study.
    Patel BM; Paratz J; See NC; Muller MJ; Rudd M; Paterson D; Briscoe SE; Ungerer J; McWhinney BC; Lipman J; Roberts JA
    Ther Drug Monit; 2012 Apr; 34(2):160-4. PubMed ID: 22406650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method.
    Carlier M; Stove V; Roberts JA; Van de Velde E; De Waele JJ; Verstraete AG
    Int J Antimicrob Agents; 2012 Nov; 40(5):416-22. PubMed ID: 22884857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic monitoring of antibiotics: New methodologies: biosensors].
    Soto D; Silva C; Andresen V M; Soto N; Wong KY; Andresen M
    Rev Med Chil; 2015 Aug; 143(8):1050-7. PubMed ID: 26436935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection.
    Briscoe SE; McWhinney BC; Lipman J; Roberts JA; Ungerer JP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():178-84. PubMed ID: 23026224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept.
    Roberts JA; Ulldemolins M; Roberts MS; McWhinney B; Ungerer J; Paterson DL; Lipman J
    Int J Antimicrob Agents; 2010 Oct; 36(4):332-9. PubMed ID: 20685085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures.
    Wong G; Briscoe S; McWhinney B; Ally M; Ungerer J; Lipman J; Roberts JA
    J Antimicrob Chemother; 2018 Nov; 73(11):3087-3094. PubMed ID: 30137377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV.
    Pinder N; Brenner T; Swoboda S; Weigand MA; Hoppe-Tichy T
    J Pharm Biomed Anal; 2017 Sep; 143():86-93. PubMed ID: 28578254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.